APA
ZOM

American Portfolios Advisors’s Zomedica Corp. ZOM Stock Holding History

American Portfolios Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-250
Closed -$55 – 3643
2022
Q2 		$55 Hold
250
– – ﹤0.01% 3501
2022
Q1 		$84 Hold
250
– – ﹤0.01% 3562
2021
Q4 		$77 Sell
250
-1,192
-83% -$537 ﹤0.01% 3488
2021
Q3 		$755 Buy
+1,442
New +$851 ﹤0.01% 3347

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PWMG
Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

American Portfolios Advisors's ZOM Position: Q3 2022 in Review

American Portfolios Advisors sold out of Zomedica Corp. (ZOM) in Q3 2022, closing a stake of 250 shares — an estimated $55 sold.

American Portfolios Advisors first reported a position in ZOM in Q3 2021 and held it in 4 quarters. The position peaked at $755 in Q3 2021. 87 funds tracked by Wall St. Rank hold ZOM as of Q3 2022.

  • American Portfolios Advisors reported no remaining Zomedica Corp. position as of Q3 2022 after selling out during the quarter.
  • American Portfolios Advisors sold 250 Zomedica Corp. shares in Q3 2022, an estimated $55.
  • American Portfolios Advisors first reported a position in Zomedica Corp. in Q3 2021 and held it in 4 quarters.
  • American Portfolios Advisors's Zomedica Corp. position peaked at $755 in Q3 2021.
  • 87 funds tracked by Wall St. Rank held Zomedica Corp. as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.